Φορτώνει......
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
The incidence and mortality of breast cancer (BCa) are the highest among female cancers. There are approximate 70% BCa that are classified as estrogen receptor alpha (ERα) positive. Therefore, targeting ERα is the most significantly therapeutic schedule. However, patients with breast cancer develop...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Biol Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Ivyspring International Publisher
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294940/ https://ncbi.nlm.nih.gov/pubmed/32549765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44005 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|